An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Clinical trial NCT01598597 · COMPLETED

Trial details

NCT number: NCT01598597
Sponsor: Genentech, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer Colorectal Cancer Non-Small Cell Lung Cancer Glioblastoma Renal Cell Cancer

Start date: 2012-03-01
Primary completion: 2014-11-01
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.